Literature DB >> 10233197

A comparative analysis of the particle size output of beclomethasone diproprionate, salmeterol xinafoate and fluticasone propionate metered dose inhalers used with the Babyhaler, Volumatic and Aerochamber spacer devices.

P W Barry1, C O'callaghan.   

Abstract

AIMS: To determine in vitro the effect of delay, inspiratory flow, and spacer washing on the drug output of metered dose inhalers (MDIs) used with different spacer devices.
METHODS: The amount of drug in particles <5 microm diameter from MDI+spacer, sampling after a delay of up to 20 s, was measured using a Multistage Liquid Impinger. Drug output was also measured at different flow rates, and after washing the Babyhaler in household detergent.
RESULTS: More fluticasone in small particles was recovered from the Babyhaler than the Volumatic or the Aerochamber spacers, and more beclomethasone and salmeterol was recovered from the Babyhaler and Volumatic spacers than from the Aerochamber. Washing the Babyhaler reduced the recovery of salmeterol, and did not alter the recovery of the other drugs tested.
CONCLUSIONS: Spacer devices need to be fully evaluated for each drug prescribed for them.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233197      PMCID: PMC2014243          DOI: 10.1046/j.1365-2125.1999.00900.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  9 in total

1.  Electrostatic charge on a plastic spacer device influences the delivery of salbutamol.

Authors:  J H Wildhaber; S G Devadason; M J Hayden; R James; A P Dufty; R A Fox; Q A Summers; P N LeSouëf
Journal:  Eur Respir J       Date:  1996-09       Impact factor: 16.671

2.  Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device.

Authors:  D J Clark; B J Lipworth
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

3.  The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler.

Authors:  P W Barry; C O'Callaghan
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

4.  Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug.

Authors:  C O'Callaghan; J Lynch; M Cant; C Robertson
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

5.  Optimum use of a spacer device.

Authors:  P W Barry; C F Robertson; C O'Callaghan
Journal:  Arch Dis Child       Date:  1993-12       Impact factor: 3.791

6.  Variation in delivery of isoprenaline from various pressurized inhalers.

Authors:  J H Bell; K Brown; J Glasby
Journal:  J Pharm Pharmacol       Date:  1973-12       Impact factor: 3.765

7.  Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids?

Authors:  P H Brown; G Blundell; A P Greening; G K Crompton
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

8.  Drug output from nebulizers is dependent on the method of measurement.

Authors:  P W Barry; C O'Callaghan
Journal:  Eur Respir J       Date:  1998-08       Impact factor: 16.671

9.  Delivery of beclomethasone dipropionate from a spacer device: what dose is available for inhalation?

Authors:  C O'Callaghan; M Cant; C Robertson
Journal:  Thorax       Date:  1994-10       Impact factor: 9.139

  9 in total
  2 in total

1.  Comparison of adverse events associated with different spacers used with non-extrafine beclometasone dipropionate for asthma.

Authors:  Simon Wan Yau Ming; John Haughney; Dermot Ryan; Shishir Patel; Matthias Ochel; Martina Stagno d'Alcontres; Susannah Thornhill; Janwillem W H Kocks; David Price
Journal:  NPJ Prim Care Respir Med       Date:  2019-02-08       Impact factor: 2.871

Review 2.  A review of the in vitro and in vivo valved holding chamber (VHC) literature with a focus on the AeroChamber Plus Flow-Vu Anti-static VHC.

Authors:  Sanjeeva Dissanayake; Jason Suggett
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.